Document ID: chunk:federal_register_of_legislation:F2025C00124:reg:8:p1
Version: federal_register_of_legislation:F2025C00124
Segment Type: reg
Provision Reference: reg 8 (pt 1/2)
Character Range: 22097–24821

8  Definition of eligible patient

Persons receiving treatment by medical practitioners at or from public hospitals other than as admitted patients
 (1) A person is an eligible patient for an HSD pharmaceutical benefit if the person:
 (a) is, or is to be treated as, an eligible person; and
 (b) is receiving medical treatment by a medical practitioner at or from a public hospital; and
 (c) is receiving that treatment as:
 (i) a non‑admitted patient of the hospital; or
 (ii) a day admitted patient of the hospital; or
 (iii) a patient on discharge from the hospital; and
 (d) is not an EFC patient (see subsection (7)) for the benefit.

Persons receiving treatment by authorised nurse practitioners at or from public hospitals other than as admitted patients—medication for the treatment of hepatitis C
 (2) A person is an eligible patient for an HSD pharmaceutical benefit that has a drug that is a medication for the treatment of hepatitis C if the person:
 (a) is, or is to be treated as, an eligible person; and
 (b) is receiving medical treatment by an authorised nurse practitioner at or from a public hospital; and
 (c) is receiving that treatment as:
 (i) a non‑admitted patient of the hospital; or
 (ii) a day admitted patient of the hospital; or
 (iii) a patient on discharge from the hospital.

Persons receiving treatment by medical practitioners in public hospitals as admitted patients—HSD pharmaceutical benefits that contain eculizumab for the treatment of atypical haemolytic uraemic syndrome
 (3) A person is an eligible patient for an HSD pharmaceutical benefit that has the drug eculizumab for the treatment of atypical haemolytic uraemic syndrome if the person:
 (a) is, or is to be treated as, an eligible person; and
 (b) is receiving medical treatment by a medical practitioner in a public hospital; and
 (c) is receiving that treatment as an admitted patient (other than a day admitted patient) of the hospital.

Persons receiving treatment by medical practitioners in, at or from private hospitals
 (4) A person is an eligible patient for an HSD pharmaceutical benefit if the person:
 (a) is, or is to be treated as, an eligible person; and
 (b) is receiving medical treatment by a medical practitioner in, at or from a private hospital; and
 (c) is not an EFC patient (see subsection (7)) for the benefit.

Persons receiving treatment by authorised nurse practitioners in, at or from private hospitals—medication for the treatment of hepatitis C
 (5) A person is an eligible patient for an HSD pharmaceutical benefit that has a drug that is a medication for the treatment of hepatitis C if the person:
 (a) is, or is to be treated as, an eligible person; and
 (b) is receiving medical treatment